AstraZeneca PLC (AZN)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Oncology Revenue	25.62B	20.28B
Oncology Revenue Growth	26.35%	18.26%
BioPharmaceuticals: CVRM Revenue	12.77B	12.45B
BioPharmaceuticals: CVRM Revenue Growth	2.62%	17.60%
BioPharmaceuticals: R&I Revenue	8.87B	7.42B
BioPharmaceuticals: R&I Revenue Growth	19.55%	21.43%
BioPharmaceuticals V&I Revenue	1.27B	1.06B
BioPharmaceuticals V&I Revenue Growth	19.85%	4.54%
Rare Disease Revenue	9.13B	8.67B
Rare Disease Revenue Growth	5.28%	11.64%
Other Medicines Revenue	988.00M	1.07B
Other Medicines Revenue Growth	-7.92%	-8.76%
Collaboration Revenue	99.00M	3.14B
Collaboration Revenue Growth	-96.84%	55.05%
Revenue (Total)	58.74B	54.07B
Revenue (Total) Growth	8.63%	18.04%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
UK Revenue	4.36B	4.74B
UK Revenue Growth	-8.04%	40.74%
Rest of Europe Revenue	13.46B	11.70B
Rest of Europe Revenue Growth	14.97%	20.34%
The Americas Revenue	27.56B	24.99B
The Americas Revenue Growth	10.28%	20.31%
Asia, Africa & Australasia Revenue	13.37B	12.64B
Asia, Africa & Australasia Revenue Growth	5.75%	5.81%
Revenue (Total)	58.74B	54.07B
Revenue (Total) Growth	8.63%	18.04%

EBIT by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
UK Operating Profit	7.07B	2.68B
UK Operating Profit Growth	163.66%	303.01%
Rest of Europe Operating Profit	5.23B	5.92B
Rest of Europe Operating Profit Growth	-11.66%	21.27%
The Americas Operating Profit	440.00M	423.00M
The Americas Operating Profit Growth	4.02%	-71.71%
Asia, Africa & Australasia Operating Profit	1.00B	976.00M
Asia, Africa & Australasia Operating Profit Growth	2.87%	-14.98%
Operating Income (Total)	13.74B	10.00B
Operating Income (Total) Growth	37.39%	22.09%

Capital Expenditures by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
UK Assets Acquired	1.76B	582.00M
UK Assets Acquired Growth	202.23%	-28.32%
Rest of Europe Assets Acquired	2.81B	2.23B
Rest of Europe Assets Acquired Growth	26.47%	25.71%
The Americas Assets Acquired	1.88B	3.93B
The Americas Assets Acquired Growth	-52.18%	103.90%
Asia, Africa & Australasia Assets Acquired	557.00M	1.39B
Asia, Africa & Australasia Assets Acquired Growth	-60.04%	1091.45%

Updated Feb 10, 2026. Data Source: Fiscal.ai.